The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mullaly, S. C.
Right arrow Articles by Kubes, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mullaly, S. C.
Right arrow Articles by Kubes, P.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Staphylococcal Infections
The Journal of Immunology, 2006, 177: 8154-8163.
Copyright © 2006 by The American Association of Immunologists, Inc.

The Role of TLR2 In Vivo following Challenge with Staphylococcus aureus and Prototypic Ligands1

Sarah C. Mullaly and Paul Kubes2

Immunology Research Group, Department of Physiology and Biophysics, Institute of Infection, Immunity, and Inflammation, University of Calgary, Calgary, Alberta, Canada

Based on a wealth of in vitro macrophage studies, immunity to Staphylococcus aureus cell wall-derived peptidoglycan (PGN) and lipoteichoic acid has been attributed to TLR2. We investigated whether the in vitro paradigm of TLR2 dominance would hold true in vivo. Using an experimental peritonitis model, we challenged mice with PGN or lipoteichoic acid and found that only PGN resulted in significant leukocyte (primarily neutrophil) accumulation in the peritoneum at 4 h. PGN-mediated leukocyte recruitment was P-/E-selectin dependent but only partially TLR2 dependent, and also involved the C5aR. Concomitant inhibition of TLR2 and C5aR resulted in a further reduction in PGN-induced peritonitis. Peritoneal neutrophilia was partially mast cell dependent; however, the defect could not be reconstituted with TLR2–/– or C5aR–/– mast cells. Interestingly, macrophage-deficient mice did not have defective neutrophil recruitment. By 24 h, the response to PGN involved primarily monocytes and was TLR2 and C5aR independent. Finally, we challenged mice with live S. aureus and found a similar degree of TLR2 involvement in leukocyte recruitment to that observed with PGN. Most importantly, bacterial clearance from the spleen and peritoneum was not altered in TLR2–/– mice vs wild-type mice. Morbidity was only significantly increased in S. aureus-infected mice treated with a blocking Fab against C5aR. Taken together, these studies indicate that in vivo responses to prototypic TLR2 ligands do not necessarily recapitulate the absolute necessity for TLR2 observed in vitro, and additional receptors contribute, in a significant manner, to PGN and S. aureus-mediated immune responses.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the Canadian Institutes of Health Research (CIHR) and a CIHR group grant. P.K. is a Canadian Research Chair recipient, the Joan Snyder Chair in Critical Care Medicine, and an Alberta Heritage Foundation for Medical Research Scientist. S.C.M. is funded by the Heart and Stroke Foundation of Canada and a Province of Alberta Graduate Scholarship.

2 Address correspondence and reprint requests to Dr. Paul Kubes, Department of Physiology and Biophysics, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta T2N 4N1, Canada. E-mail address: pkubes{at}ucalgary.ca

3 Abbreviations used in this paper: PAMP, pathogen-associated molecular pattern; LTA, lipoteichoic acid; PGN, peptidoglycan; BMMC, bone marrow-derived mast cell; MPO, myeloperoxidase.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Phillipson, B. Heit, S. A. Parsons, B. Petri, S. C. Mullaly, P. Colarusso, R. M. Gower, G. Neely, S. I. Simon, and P. Kubes
Vav1 Is Essential for Mechanotactic Crawling and Migration of Neutrophils out of the Inflamed Microvasculature
J. Immunol., June 1, 2009; 182(11): 6870 - 6878.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. M. Burke, T. B. Issekutz, K. Mohan, P. W. K. Lee, M. Shmulevitz, and J. S. Marshall
Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism
Blood, June 15, 2008; 111(12): 5467 - 5476.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. M. Kelly, K. McNagny, D. L. Williams, N. van Rooijen, L. Maxwell, C. Gwozd, C. H. Mody, and P. Kubes
The Lung Responds to Zymosan in a Unique Manner Independent of Toll-Like Receptors, Complement, and Dectin-1
Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 227 - 238.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. S. Zhou, W. Xing, D. S. Friend, K. F. Austen, and H. R. Katz
Mast cell deficiency in KitW-sh mice does not impair antibody-mediated arthritis
J. Exp. Med., November 26, 2007; 204(12): 2797 - 2802.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Burke, L. M. Ganley-Leal, A. Khatri, and L. M. Wetzler
Neisseria meningitidis PorB, a TLR2 Ligand, Induces an Antigen-Specific Eosinophil Recall Response: Potential Adjuvant for Helminth Vaccines?
J. Immunol., September 1, 2007; 179(5): 3222 - 3230.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Watanabe, M. Ichiki, A. Shiratsuchi, and Y. Nakanishi
TLR2-Mediated Survival of Staphylococcus aureus in Macrophages: A Novel Bacterial Strategy against Host Innate Immunity
J. Immunol., April 15, 2007; 178(8): 4917 - 4925.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.